A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Managing director & CEO Siddharth Mittal says is de-risking supply chain as Trump tariffs loom. 'We’re scenario-mapping but there’s a limit to how much we can do,' he tells Moneycontrol ...

Cleaning his plate — and sometimes a second plate — was a household requirement during Charles’s childhood. “It served me ...

Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...

A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

The S&P 500 slid 0.1% on Thursday, Aug. 7, 2025, as new tariffs took effect, raising import duties on goods from numerous U.S. trading partners.

Otto’s, a French restaurant in London known for rich feasts of canard à la presse, lobster soufflé and crêpes suzette, introduced a “menu for one, small appetite” in May. The tasting menu, which costs ...